90 related articles for article (PubMed ID: 20828556)
1. Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells.
Källquist L; Rosén H; Nordenfelt P; Calafat J; Janssen H; Persson AM; Hansson M; Olsson I
Exp Cell Res; 2010 Nov; 316(19):3182-96. PubMed ID: 20828556
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil elastase sorting involves plasma membrane trafficking requiring the C-terminal propeptide.
Tapper H; Källquist L; Johnsson E; Persson AM; Hansson M; Olsson I
Exp Cell Res; 2006 Nov; 312(18):3471-84. PubMed ID: 16950244
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil elastase-processing defect in cyclic hematopoietic dogs.
Meng R; Bridgman R; Toivio-Kinnucan M; Niemeyer GP; Vernau W; Hock T; Lothrop CD
Exp Hematol; 2010 Feb; 38(2):104-15. PubMed ID: 19941936
[TBL] [Abstract][Full Text] [Related]
4. The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway.
Lau AW; Chou MM
J Cell Sci; 2008 Dec; 121(Pt 24):4008-17. PubMed ID: 19033387
[TBL] [Abstract][Full Text] [Related]
5. The tetraspanin CD63 is involved in granule targeting of neutrophil elastase.
Källquist L; Hansson M; Persson AM; Janssen H; Calafat J; Tapper H; Olsson I
Blood; 2008 Oct; 112(8):3444-54. PubMed ID: 18669870
[TBL] [Abstract][Full Text] [Related]
6. Trafficking and function of the tetraspanin CD63.
Pols MS; Klumperman J
Exp Cell Res; 2009 May; 315(9):1584-92. PubMed ID: 18930046
[TBL] [Abstract][Full Text] [Related]
7. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase.
Benson KF; Li FQ; Person RE; Albani D; Duan Z; Wechsler J; Meade-White K; Williams K; Acland GM; Niemeyer G; Lothrop CD; Horwitz M
Nat Genet; 2003 Sep; 35(1):90-6. PubMed ID: 12897784
[TBL] [Abstract][Full Text] [Related]
8. Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase.
Hajjar E; Korkmaz B; Reuter N
FEBS Lett; 2007 Dec; 581(29):5685-90. PubMed ID: 18023421
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
[TBL] [Abstract][Full Text] [Related]
10. Structures of human proteinase 3 and neutrophil elastase--so similar yet so different.
Hajjar E; Broemstrup T; Kantari C; Witko-Sarsat V; Reuter N
FEBS J; 2010 May; 277(10):2238-54. PubMed ID: 20423453
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitously expressed secretory carrier membrane proteins (SCAMPs) 1-4 mark different pathways and exhibit limited constitutive trafficking to and from the cell surface.
Castle A; Castle D
J Cell Sci; 2005 Aug; 118(Pt 16):3769-80. PubMed ID: 16105885
[TBL] [Abstract][Full Text] [Related]
12. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing.
von Vietinghoff S; Eulenberg C; Wellner M; Luft FC; Kettritz R
Clin Exp Immunol; 2008 Jun; 152(3):508-16. PubMed ID: 18462208
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis of the glucose transporter GLUT8 is mediated by interaction of a dileucine motif with the beta2-adaptin subunit of the AP-2 adaptor complex.
Schmidt U; Briese S; Leicht K; Schürmann A; Joost HG; Al-Hasani H
J Cell Sci; 2006 Jun; 119(Pt 11):2321-31. PubMed ID: 16723738
[TBL] [Abstract][Full Text] [Related]
15. Computational prediction of the binding site of proteinase 3 to the plasma membrane.
Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N
Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025
[TBL] [Abstract][Full Text] [Related]
16. Differential use of two AP-3-mediated pathways by lysosomal membrane proteins.
Ihrke G; Kyttälä A; Russell MR; Rous BA; Luzio JP
Traffic; 2004 Dec; 5(12):946-62. PubMed ID: 15522097
[TBL] [Abstract][Full Text] [Related]
17. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
[TBL] [Abstract][Full Text] [Related]
18. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
19. CD63 associates with tyrosine kinase activity and CD11/CD18, and transmits an activation signal in neutrophils.
Skubitz KM; Campbell KD; Iida J; Skubitz AP
J Immunol; 1996 Oct; 157(8):3617-26. PubMed ID: 8871662
[TBL] [Abstract][Full Text] [Related]
20. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
